MUSC Hollings researchers create AI tool that predicts chronic graft-versus-host disease risk after stem cell and bone marrow transplants.
YorChip announces two key initiatives as part of a comprehensive effort to jumpstart Chiplet adoption for the Physical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results